So on that note, Pyxis Tankers (NASDAQ:PXS) looks quite promising in regards to its trends of return on capital. Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Blackmagic finally answered the prayers of filmmakers everywhere with the Blackmagic PYXIS 6K. This next-generation digital film camera ditches the traditional form factor for a versatile box ...

First, a Sony and Panasonic-rivalling Pyxis 6K modular camera for indie filmmakers; the latest version of its popular video editing platform Davinci Resolve 19 – which we rate as the best free ...

Blackmagic has launched the Ursa Cine 12K and Pyxis 6K cameras. The Ursa Cine 12K, available from resellers now for $14,995 (£12,020), offers a large format RGBW 36 x 24mm sensor with larger ...

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

Non-dilutive funding to support development of first-in-concept lead Antibody-Drug Conjugate (ADC) asset, PYX-201 Pyxis Oncology retains rights to three other antibodies in development by Apexigen ...

First, a Sony and Panasonic-rivalling Pyxis 6K modular camera for indie filmmakers; the latest version of its popular video editing platform Davinci Resolve 19 – which we rate as the best free ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...